# OnCo record nct05827614 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05827614/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05827614", "NCT05827614" ;
  schema:name "Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications"@en ;
  schema:description "A phase 1 trial of BBI-355 run by Boundless Bio, Inc., terminated."@en ;
  schema:url <https://onco.cc/trials/nct05827614/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05827614> ;
  onco:status "historic" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/tnbc/>, <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/head-and-neck/>, <https://onco.cc/cancers/cutaneous-scc/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/breast-cancer/>, <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/undifferentiated-pleomorphic-sarcoma/>, <https://onco.cc/cancers/metastatic-cancer/>, <https://onco.cc/cancers/sclc/> ;
  onco:drugs <https://onco.cc/drugs/bbi-355/>, <https://onco.cc/drugs/bbi-825/> ;
  onco:companies <https://onco.cc/companies/boundless-bio/> .